Collecting and Storing Blood, Bone Marrow, and Other Samples From Patients With Acute Leukemia, Chronic Leukemia, or Myelodysplastic Syndromes
This study has been withdrawn prior to enrollment.
Sponsor:
Alliance for Clinical Trials in Oncology
Collaborator:
Information provided by:
Alliance for Clinical Trials in Oncology
ClinicalTrials.gov Identifier:
NCT00899223
First received: May 9, 2009
Last updated: July 11, 2013
Last verified: February 2013
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
RATIONALE: Collecting and storing samples of blood, bone marrow, and DNA from other tissues from patients with cancer to study in the laboratory may help in the study of cancer.
PURPOSE: This laboratory study is collecting and storing blood, bone marrow, and other samples from patients with acute leukemia, chronic leukemia, or myelodysplastic syndromes.
| Condition | Intervention |
|---|---|
|
Leukemia Lymphoma Myelodysplastic Syndromes Myelodysplastic/Myeloproliferative Neoplasms |
Other: biologic sample preservation procedure |
| Study Type: | Observational |
| Official Title: | The CALGB Leukemia Tissue Bank |
Resource links provided by NLM:
Genetic and Rare Diseases Information Center resources:
Acute Lymphoblastic Leukemia
Acute Lymphoblastic Leukemia, Childhood
Acute Monoblastic Leukemia
Acute Myeloblastic Leukemia Type 5
Acute Myelocytic Leukemia
Acute Myeloid Leukemia, Adult
Acute Myeloid Leukemia, Childhood
Acute Non Lymphoblastic Leukemia
Chronic Lymphocytic Leukemia
Chronic Myeloid Leukemia
Chronic Myelomonocytic Leukemia
Chronic Myeloproliferative Disorders
Hairy Cell Leukemia
Juvenile Myelomonocytic Leukemia
Leukemia, B-cell, Chronic
Leukemia, Myeloid
Leukemia, T-cell, Chronic
Lymphosarcoma
Myelodysplastic Syndromes
Myelodysplastic/myeloproliferative Disease
U.S. FDA Resources
Further study details as provided by Alliance for Clinical Trials in Oncology:
Primary Outcome Measures:
- Collection and storage of specimens from newly diagnosed patients with acute or chronic leukemia or myelodysplastic syndromes enrolled on a CALGB protocol [ Designated as safety issue: No ]
| Enrollment: | 0 |
| Study Start Date: | May 1996 |
OBJECTIVES:
- Collect and store specimens from newly diagnosed patients with acute or chronic leukemia or myelodysplastic syndromes enrolled on a CALGB protocol.
OUTLINE: This is a multicenter study.
Bone marrow aspirate and blood specimens are obtained from patients at diagnosis, remission, or relapse and stored. Buccal smears are obtained at diagnosis, and DNA is extracted and preserved.
PROJECTED ACCRUAL: Samples from approximately 1,500 patients will be collected for this study within 5 years.
Eligibility| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | No |
Criteria
DISEASE CHARACTERISTICS:
-
One of the following diagnoses:
- Acute leukemia
- Chronic leukemia
- Myelodysplastic syndrome
- Newly diagnosed disease
- Enrolled on a CALGB treatment protocol
- Must enroll on this study before receiving any therapy for malignancy
PATIENT CHARACTERISTICS:
- Not specified
PRIOR CONCURRENT THERAPY:
- Not specified
Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study.
To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below.
For general information, see Learn About Clinical Studies.
Please refer to this study by its ClinicalTrials.gov identifier: NCT00899223
Show 142 Study Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00899223
Show 142 Study Locations
Sponsors and Collaborators
Alliance for Clinical Trials in Oncology
Investigators
| Study Chair: | Michael A. Caligiuri, MD | Ohio State University Comprehensive Cancer Center |
More Information
Publications:
| ClinicalTrials.gov Identifier: | NCT00899223 History of Changes |
| Other Study ID Numbers: | CDR0000271412, U10CA031946, CALGB-9665 |
| Study First Received: | May 9, 2009 |
| Last Updated: | July 11, 2013 |
| Health Authority: | Unspecified |
Keywords provided by Alliance for Clinical Trials in Oncology:
|
accelerated phase chronic myelogenous leukemia acute lymphocytic leukemia acute undifferentiated leukemia blastic phase chronic myelogenous leukemia chronic myelomonocytic leukemia chronic phase chronic myelogenous leukemia meningeal chronic myelogenous leukemia progressive hairy cell leukemia, initial treatment prolymphocytic leukemia stage 0 chronic lymphocytic leukemia stage I adult T-cell leukemia/lymphoma stage I chronic lymphocytic leukemia stage II adult T-cell leukemia/lymphoma stage II chronic lymphocytic leukemia stage III adult T-cell leukemia/lymphoma |
stage III chronic lymphocytic leukemia stage IV adult T-cell leukemia/lymphoma stage IV chronic lymphocytic leukemia untreated adult acute lymphoblastic leukemia untreated adult acute myeloid leukemia untreated childhood acute lymphoblastic leukemia untreated childhood acute myeloid leukemia and other myeloid malignancies untreated hairy cell leukemia de novo myelodysplastic syndromes myelodysplastic/myeloproliferative neoplasm, unclassifiable secondary myelodysplastic syndromes secondary acute myeloid leukemia juvenile myelomonocytic leukemia childhood myelodysplastic syndromes |
Additional relevant MeSH terms:
|
Leukemia Myelodysplastic Syndromes Myelodysplastic-Myeloproliferative Diseases Myeloproliferative Disorders Preleukemia |
Bone Marrow Diseases Hematologic Diseases Neoplasms Neoplasms by Histologic Type Precancerous Conditions |
ClinicalTrials.gov processed this record on March 03, 2015